Search

everythinglearnresearchcommunity

for

Search:↓

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Hair analysis can show nutritional status and environmental exposure, with phosphorus being very stable in hair and differences found based on gender and conditions like depression and autism.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

Cationic polymers improved liposome stability and increased skin absorption of aciclovir and minoxidil.

Scientists created a gel with nanoparticles to deliver medicine to hair follicles effectively.

Reversed sequential therapy with cyproterone acetate was effective for treating women with hirsutism and related conditions.

Nano-sized lipid particles increase dexamethasone's skin penetration and create a reservoir in the skin layers.

Topical imiquimod use for treating a cervical lesion might cause delayed hair loss.

Some medications can cause rare hair color changes, and reporting these side effects is important for patient quality of life.

Keratin films from human hair can potentially replace human nail plates for drug testing.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

PRP therapy is a safe and effective treatment for hair loss.

Methylated flavonoids may effectively reduce depression and inflammation caused by finasteride.

Women with irregular periods have a higher risk of heart disease.

Methylation in specific gene region causes finasteride resistance in some BPH patients.

A specific gene mutation (Y449H in K10) was found in a patient with severe skin disorder.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Thicker hair grows faster; hair loss patients have slower growth.

Iron chloride helps create compounds that could be useful in medicine, like treating hair loss.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

Low dose valproic acid treatment caused hair loss in a young patient.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Finasteride doesn't affect omeprazole metabolism in Japanese people.

An older woman had false beliefs after taking a depression medication, which stopped when she stopped the medication.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

European patent law now allows patents for new uses and dosages of known drugs, but protection scope is unclear.